Danaher (NYSE:DHR) First Quarter 2025 Results

Key Financial Results

• Revenue: US$5.74b (flat on 1Q 2024).
• Net income: US$954.0m (down 12% from 1Q 2024).
• Profit margin: 17% (down from 19% in 1Q 2024).
• EPS: US$1.33 (down from US$1.47 in 1Q 2024).

We check all companies for important risks. See what we found for Danaher in our free report.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Danaher Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 2.7%. Earnings per share (EPS) also surpassed analyst estimates by 9.5%.

Looking ahead, revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 5.8% growth forecast for the Life Sciences industry in the US.

Performance of the American Life Sciences industry.

The company's shares are up 1.1% from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. See our latest analysis on Danaher's balance sheet health.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.